FDA — authorised 30 April 1998
- Application: NDA020896
- Marketing authorisation holder: CHEPLAPHARM
- Status: supplemented
FDA authorised Xeloda on 30 April 1998
Yes. FDA authorised it on 30 April 1998; FDA has authorised it.
CHEPLAPHARM holds the US marketing authorisation.